Abstract

Hepatic sinusoidal obstruction syndrome (SOS/VOD) represents a dramatic complication of hematopoietic stem cell transplantation (HSCT), particularly in children. Recent evidence has suggested a role for the gut microbiome (GM) in the context of HSCT and its related complications, but no data are available on the relationship between GM and SOS/VOD. Here, we conducted a retrospective case–control study in allo-HSCT pediatric patients developing or not SOS/VOD and profiled their GM over time, from before the transplant up to 72 days after. A rich and diverse GM before HSCT was found to be associated with a reduced likelihood of developing SOS/VOD. Furthermore, prior to transplant, patients not developing SOS/VOD showed an enrichment in some typically health-associated commensals, such as Bacteroides, Ruminococcaceae and Lachnospiraceae. Their levels remained overall higher until post-transplant. This high-diversity configuration resembles that described in other studies for other HSCT-related complications, including graft-versus-host disease, potentially representing a common protective GM feature against HSCT complications.

Details

Title
Early modifications of the gut microbiome in children with hepatic sinusoidal obstruction syndrome after hematopoietic stem cell transplantation
Author
Masetti Riccardo 1 ; Biagi, Elena 2 ; Zama Daniele 3 ; Muratore Edoardo 3 ; D’Amico Federica 4 ; Leardini Davide 3   VIAFID ORCID Logo  ; Turroni Silvia 2   VIAFID ORCID Logo  ; Prete Arcangelo 3 ; Brigidi Patrizia 5 ; Pession, Andrea 1 

 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Pediatric Oncology and Hematology “Lalla Seràgnoli”, Pediatric Unit, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758); University of Bologna, Department of Medical and Surgical Sciences (DIMEC), Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758) 
 University of Bologna, Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758) 
 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Pediatric Oncology and Hematology “Lalla Seràgnoli”, Pediatric Unit, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758) 
 University of Bologna, Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758); University of Bologna, Department of Medical and Surgical Sciences (DIMEC), Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758) 
 University of Bologna, Department of Medical and Surgical Sciences (DIMEC), Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2550562480
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.